A recent Phase III trial has kicked off to evaluate the effectiveness of an innovative antibiotic called Compound X in the management of urinary tract infections (UTIs). The research initiative is being conducted at multiple sites across the globe and will recruit thousands of participants with different types of UTIs. Clinical Trialists are expect